Home/Pipeline/High-Definition Spinal Cord Stimulation

High-Definition Spinal Cord Stimulation

Chronic Pain

UnknownActive

Key Facts

Indication
Chronic Pain
Phase
Unknown
Status
Active
Company

About Micro-Leads

Micro-Leads is pioneering next-generation, closed-loop neuromodulation with a focus on high-resolution, minimally-invasive devices. Its core platform integrates smart programmable electrodes, shape-memory percutaneous arrays, and custom application-specific integrated circuits (ASICs) to enable precise neural interfacing for chronic pain, sensory-motor paralysis, and other neurological disorders. The company is in the clinical development stage, positioning its technology as a potential solution for patients who have exhausted existing therapeutic options. Its innovative approach seeks to move neuromodulation from a broad, low-resolution intervention to a targeted, personalized medicine.

View full company profile

Other Chronic Pain Drugs

DrugCompanyPhase
SCI-160SciSparcPreclinical
Injectrode Platform for Chronic PainNeuronoffPre-clinical
Novel PNS SystemNervonikFirst-in-Human Completed
Pain PipelineCentrexion TherapeuticsClinical Stage
Precision Medicine for PainMindX SciencesCommercial
Chronic Pain ProgramCurrent SurgicalResearch
N-19aNeurocarrusPre-clinical
Nav1.7 ASOQuiver BioscienceDiscovery
Nav1.8 ASOQuiver BioscienceDiscovery
Dual Nav1.7/1.8 ASOQuiver BioscienceDiscovery
TMS for Chronic PainMagstimCommercial/Clinical Development
Platform EnhancementsNevroR&D